Audrey Commault

Dr. Audrey Commault

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in Bioresource Technology
Verified
Journal Article
Closed access
ACAudrey Commault
Audrey Commault
GLGavin Lear
Gavin Lear
Michael PackerMichael Packer
Michael Packer
RWRichard J. Weld
Richard J. Weld

1 July 2017 in Journal of Power Sources
Verified
Journal Article
Closed access
ACAudrey Commault
Audrey Commault
OLOlivier Laczka
Olivier Laczka
NSNachshon Siboni
Nachshon Siboni
BTBojan Tamburic
Bojan Tamburic
JCJoseph Crosswell
Joseph Crosswell
PRPeter J. Ralph
Peter J. Ralph

1 February 2020 in Science of The Total Environment
Verified
Journal Article
Closed access
Nguyen LuongNguyen Luong
Nguyen Luong
ACAudrey Commault
Audrey Commault
TKTim Kahlke
Tim Kahlke
PRPeter J. Ralph
Peter J. Ralph
GSGalilee U. Semblante
Galilee U. Semblante
Long NghiemLong Nghiem
Long Nghiem

5 March 2020 in Cells
Verified
Journal Article
Open access
PDF file
LBLorenzo Barolo
Lorenzo Barolo
RARaffaela Abbriano
Raffaela Abbriano
ACAudrey Commault
Audrey Commault
JGJestin George
Jestin George
TKTim Kahlke
Tim Kahlke
MPMathieu Pernice
Mathieu Pernice
Microalgae exhibit great potential for recombinant therapeutic protein production, due to lower production costs, immunity to human pathogens, and advanced genetic toolkits. However, a fundamental aspect to consider for recombinant biopharmaceutical production is the presence of correct post-translational modifications. Multiple recent studies focusing on glycosylation in microalgae have revealed unique species-specific patterns absent in humans. Glycosylation is particularly important for protein function and is directly responsible for recombinant biopharmaceutical immunogenicity. Therefore, it is necessary to fully characterise this key feature in microalgae before these organisms can be established as industrially relevant microbial biofactories. Here, we review the work done to date on production of recombinant biopharmaceuticals in microalgae, experimental and computational evidence for N- and O-glycosylation in diverse microalgal groups, established approaches for glyco-engineering, and perspectives for their application in microalgal systems. The insights from this review may be applied to future glyco-engineering attempts to humanize recombinant therapeutic proteins and to potentially obtain cheaper, fully functional biopharmaceuticals from microalgae.

1 November 2016 in Algal Research
Verified
Journal Article
Closed access
NTNhan-An T. Tran
Nhan-An T. Tran
Matthew PadulaMatthew Padula
Matthew Padula
CEChristian R. Evenhuis
Christian R. Evenhuis
ACAudrey Commault
Audrey Commault
PRPeter J. Ralph
Peter J. Ralph
BTBojan Tamburic
Bojan Tamburic

1 December 2015 in Bioelectrochemistry
Verified
Journal Article
Closed access
ACAudrey Commault
Audrey Commault
GLGavin Lear
Gavin Lear
RWRichard J. Weld
Richard J. Weld